50% off Premium Yearly

NYSE:VTR
This summary was created by AI, based on 3 opinions in the last 12 months.
Ventas Inc (VTR-N) stands out in the healthcare REIT sector, particularly in seniors housing, which presents a significant growth opportunity. The company's nursing homes rank as the best in their category and are valued at 20 times FFO with a strong earnings growth rate of 10%. Additionally, Ventas's retirement homes have demonstrated remarkable performance, with a staggering 2,177% increase in shares since 2000. The firm has maintained a consistent upward trajectory, reflected by a nearly 20% average annual gain over the past 25 years while also possessing the lowest price-to-earnings ratio within its sector. Led by the same CEO since 1999, Ventas has seen a 17% rise this year, indicating that while the stock may be slightly overbought, investors are encouraged to buy on dips for gradual accumulation.
He likes the healthcare space, and this company owns medical office buildings, seniors’ homes, etc. This is generally a good business. However, being structured as a REIT, it has had a huge, huge run in share price and trades at a fairly steep valuation. It is vulnerable to interest rates coming down. He prefers Capital Senior Living (CSU-N) which trades at a much more modest valuation. Dividend yield of 4.2%.
A healthcare REIT. He owns a similar one. They are growth vehicles and trade significantly above NAV because they are constantly acquiring. The prices come off when there is a sign their acquisitions will drop off. They are looking at Canada. He thinks you are better buying companies they may want to acquire, however.
Seniors housing REIT in the US. He likes it. It has been clobbered. The decline is based on the broader US REIT index. People are getting older and you should see an increase in demand for seniors housing. You should see good rent increases. It is a little bit growth by acquisition based which is harder when you are trading at a discount.
Ventas Inc is a American stock, trading under the symbol VTR (previously VTR-N on Stockchase) on the New York Stock Exchange (VTR). It is usually referred to as NYSE:VTR or VTR
In the last year, 3 stock analysts issued a Buy, Sell, or Hold rating on VTR (previously VTR-N on Stockchase). 3 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is . Read the latest stock experts' ratings for Ventas Inc.
Ventas Inc was recommended as a Top Pick by Derek Warren on 2014-06-13. Read the latest stock experts ratings for Ventas Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Ventas Inc.
Ventas Inc is followed by 8 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-16, Ventas Inc (VTR) stock closed at a price of $83.89.
Nursing homes. 20x FFO and 10% earnings growth.